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Abstract
Background: Leiomyosarcoma are malignant tumours of the soft tissues. It is most commonly
found in the stomach, small intestine and retroperitoneum. Primary pancreatic leiomyosarcoma is
extremely rare and only 22 cases have been reported in the literature since 1951. Its prognosis is
poor and the palliative treatment is only aimed at symptomatic improvement.
Case presentation: We report case of primary pancreatic leiomyosarcoma with liver metastases
in a 73 year old man who presented with weight loss, epigastric pain, anorexia, abdominal fullness
and obstructive jaundice. Histological examination and Immunohistochemical analysis of liver
biopsy specimen confirmed the diagnosis of metastatic leiomyosarcoma. The patient died of disease
3 months after the initial diagnosis.
Conclusion: Leiomyosarcoma of the pancreas is an extremely rare malignancy with a poor
prognosis. Treatment is aimed at symptomatic improvement and pain management.
Background
The incidence rate for pancreatic cancer is approximately
nine new cases per 100,000 people, with the peak inci-
dence in the seventh and eighth decades of life and an
average age of 60 to 65 years at diagnosis [1]. The com-
monest type is an adenocarcinoma.
Primary pancreatic leiomyosarcoma is a rare malignant
neoplasm. It accounts for 0.1% of malignant pancreatic
cancers [1]. A review of the literature reveals 22 such cases
published so far [2]. The majority of the reported cases
were diagnosed on autopsy.
Survival in patients with untreated PC is poor. For all
stages combined, the 1-year survival rate is 19% and the 5-
year survival rate is 4% [1]. The majority (80%) of PCs are
metastatic at the time of diagnosis. Surgical resection
(when margin negative, node negative) offers the best
possibility for cure, with 5-year survival approaching 40%
when performed at specialized major medical institutions
[3].
We report a case of Primary leiomyosarcoma of Pancreas
occurring in a 73 years old male.
Case presentation
A 73 years old male presented with 1 month history of
weight loss of 16 kilograms, epigastric pain, anorexia,
abdominal fullness and jaundice. He was recently diag-
nosed with diabetes mellitus. Liver was palpable on exam-
ination of his abdomen. He had a raised bilirubin and
liver enzymes. Abdominal ultrasound & CT scan demon-
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strated an enlarged liver containing multiple irregular ill
defined lesions including the caudate lobe suggestive of
metastases. There was a large enhancing soft tissue mass
with a central necrotic area approximately measuring 9.4
× 10 cms in the region of the body of pancreas. This mass
was compressing splenic artery and vein. The patient
underwent Ultrasound guided liver biopsy. Histological &
Immunohistochemical analysis confirmed leiomyosar-
coma of the pancreatic origin. This case was discussed in
relevant multidisciplinary team meeting. As his disease
was already in advanced metastatic phase so he was
offered palliative chemotherapy. His condition deterio-
rated before the chemotherapy & he died after 3 months
of the initial diagnosis. No autopsy was conducted.
Histological examination was suggestive of Spindle cell
neoplasm (Figures 1 &2). The spindle cells showed mild
to moderate nuclear pleomorphism & anisocytosis. There
was generally less than 1 mitotic figure per high power
field & no abnormal mitotic figures were seen. The spindle
cells were positive for desmin & smooth muscle actin.
These were negative for cytokeratin (AE1/AE3), HMB45,
S100 protein, melanin A, NSE (neuron specific enolase),
CD34 and CD 117. The immune profile was suggestive of
leiomyosarcoma.
In conclusion, the histological & Immunohistochemical
features of the tumour were consistent with low to inter-
mediate grade leiomyosarcoma.
Discussion
Primary pancreatic leiomyosarcoma is a rare malignant
neoplasm reported in world literature by only 22 cases up
to this time.
We report a case of primary pancreatic leiomyosarcoma.
This tumour was involving the body of the pancreas with
direct invasion of the splenic vessels along with multiple
hepatic secondaries. Complete clinical and radiological
evaluation excluded secondary pancreatic involvement by
a sarcoma of the retroperitoneal and gastrointestinal ori-
gin. Immunohistochemical analysis of the samples con-
firmed this tumour as a smooth muscle sarcoma.
Leiomyosarcomas involving pancreas consist of primary
pancreatic leiomyosarcoma or pancreatic extensions of
retroperitoneal and gastro-duodenal sarcomas [2]. Pan-
creatic mesenchymal tumours consist of malignant
peripheral nerve sheath tumours, malignant fibrous histi-
ocytomas, liposarcomas, rhabdomyosarcomas, hemiperi-
cytomas & leiomyosarcomas [3]. A detailed clinical
evaluation is essential to rule out a primary extra pancre-
atic leiomyosarcomas. Female genital tract, gastrointesti-
nal tract, soft tissues of the extremities and
retroperitoneum are the most commonly affected areas
[2].
Table 1 summarizes the clinicopathological data of the 22
reported cases of pancreatic leiomyosarcoma. Abdominal
pain, weight loss, epigastric tenderness & abdominal mass
are the most commonly presenting symptoms [4]. Pancre-
atic leiomyosarcoma is more common in fifth decade of
life or older (mean age 44.7 years; range 14 to 80 years).
Photomicrograph of the liver biopsy stained with Haematox- ylin and Eosin (H&E) Original magnification × 200 Figure 1
Photomicrograph of the liver biopsy stained with 
Haematoxylin and Eosin (H&E) Original magnifica-
tion × 200.
 
Photomicrograph of the liver biopsy stained with smooth  muscle actin (SMA) Original magnification × 200. Figure 2
Photomicrograph of the liver biopsy stained with 
smooth muscle actin (SMA) Original magnification × 
200.
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Males are affected almost twice as compared to females
(7:4). The size of the tumours is quite variable ranging
from 3 cm to 25 cm (Median,10.5 cm). It is observed that
larger tumour can develop cystic degeneration & can be
misdiagnosed as pseudocysts of pancreas [4].
In the documented literature, about 43.5% (10 patients)
presented with locally advanced or metastatic disease.
First ever case of pancreatic leiomyosarcoma was diag-
nosed on autopsy [5]. Three patients died at 3,9 and 33
months respectively after the diagnosis [6,7]. We do not
know precisely about the survival outcome of remaining
6 patients.
At the time of diagnosis of leiomyosarcoma, only 13 cases
seem to be localised to pancreas & underwent surgical
Table 1: Clinicopathological data of reported cases.
Case Number Year Author Age/Sex Clinical features Morphological 
Findings
Clinical 
management & 
outcome
1 1951 Ross 80/M Weight loss, mass, 
LUQ
Whole pancreas; wide 
spread metastases 
without lymph node 
involvement
Autopsy case
2 1956 Berman & Levene 47/M Jaundice Head of pancreas;5.5 
cm; no metastases
Pancreatodudenectom
y ; well 1 year later
3 1957 Feinberg et al 14/M Epigastric pain; nausea Head;11 cm; no 
metastases
Pancreatodudenectom
y
4 1965 Becker et al No data available No data available Cystic change No data available
5 1970 Oyamada et al 47/M General fatigue, mass, 
LUQ
15 cm Nonresectable
6–10 1973 Baylor & Berg 
(5 cases)
51 (Median), M:3, F:2 No data available Localized:1;Locally 
advanced:1;Disseminat
ed:3
No data available
11 1976 Carda et al 56/F Nausea & vomiting Whole pancreas Gastrostomy; died in 9 
months
12 1981 Ishikawa et al 44/M Epigastric pain, mass Head;8 cm,; localized 
at operation
Pancreatodudenectom
y; liver metastases 4 
years later
13 1982 Tulha et al 28/F Weight loss, mass Head;20 cm Pancreatodudenectom
y ; Lung & liver 
metastases 15 months 
later
14 1990 Murata et al 55/F No data available Head & tail; no 
metastases
Caudal 
pancreatectomy
15 1991 Lakhoo & Mannell 68/M Abdominal pain, 
weight loss, mass
Body;17 cm; no 
metastases
Distal pancreatectomy, 
gastric resection & 
transverse colectomy; 
well 2 years later
16 1993 De Alava et al 71/M Abdominal pain, 
weight loss
Body;3.6 cm; no 
metastases
Pancreatectomy
17 1994 Peskova & Fried 68/F Malena Head;15 cm; localized Pancreatodudenectom
y;well 3 years later
18 1994 Sato et al 53/F Abdominal pain, mass Body;25 cm; no 
metastases
Distal pancreatectomy
19 1994 Ishii et al 66/M Incidental finding Tail;14 cm; wide 
spread metastases 
without lymph node 
involvement
Nonresectable
20 1995 Aranha et al 46/F Epigastric pain, 
nausea, vomiting
Body;3 cm; localized Distal pancreatectomy; 
dead in 9 months
21 1997 Owen et al 40/M Abdominal pain Head;6 cm; no 
metastases
Pancreatodudenectom
y; well 10 year later
22 2000 Nesi et al 76/M Fever Tail;8 cm; localized Distal pancreatectomy; 
dead in 12 months
23 2007 Present case 73/M Weight loss, 
Epigastric pain, 
abdominal mass
Body;10 cm, hepatic 
metastases
Nonresectable; dead in 
3 monthsPublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Cases Journal 2008, 1:280 http://www.casesjournal.com/content/1/1/280
Page 4 of 4
(page number not for citation purposes)
resection. Followup details are available for only 8
patients. Four patients died of their tumours with in four
years time after the initial diagnosis [6,8,9]. Remaining 4
patients were alive & free of symptoms at 1,3,4,6 years
after the initial surgical management [10-12].
Large tumour size is not a precise predictor of adverse out-
come. In leiomyomatous tumours mitotic figures are pro-
posed to present the important predicting parameter [13].
Mitotic counts of more than 10 mitoses/10 HPFs is asso-
ciated with a worse outcome [2].
Conclusion
The number of cases of pancreatic leiomyosarcoma
reported in world literature is limited but what we have
learnt that it is a highly malignant tumour which can be
metastatic even on first presentation. Extensive surgical
resection of tumour is still the best treatment option for
localised disease. Metastatic pancreatic leiomyosarcomas
have shown only a partial response to chemotherapy.
Treatment is aimed at symptomatic improvement and
pain management.
Consent
Written informed consent could not be obtained since the
patient is deceased and the next of kin were untraceable.
We believe this case report contains a worthwhile clinical
lesson which could not be as effectively made in any other
way. We expect that the next of kin would not object to the
publication since the patient remains anonymous.
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